Navigation Links
ISTA Pharmaceuticals Reports Third Quarter 2010 Financial Results
Date:11/2/2010

IRVINE, Calif., Nov. 2, 2010 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. (Nasdaq: ISTA), today reported financial results for the quarter ended September 30, 2010.  Third quarter 2010 net revenues were $42.0 million, an increase of 31% from the third quarter of 2009.  Excluding the recognition of one-time license revenue in the third quarter of 2009, net product revenues increased 44%.  Net loss for the third quarter ended September 30, 2010, was $23.5 million, or $0.70 per diluted share, compared to a net loss of $917,000, or $0.03 per diluted share, for the third quarter ended September 30, 2009.  Excluding non-cash warrant valuation adjustments and license revenue, net income for the third quarter of 2010 was $2.8 million, or $0.08 per diluted share compared to a loss of $0.4 million, or $0.01 per diluted share in the third quarter of 2009.

"These are exciting times at ISTA.  After a strong first half of the year, the third quarter demonstrates that we are on track for an equally strong second half.  Not only are we posting revenue growth for all four products and delivering improved operating profitability, we are achieving key new product pipeline milestones," stated Vicente Anido, Jr., Ph.D., President and Chief Executive Officer of ISTA.  "Most recently, we announced the U.S. Food and Drug Administration (FDA) approved BROMDAY™ (bromfenac ophthalmic solution) 0.09% (formerly known as XiDay), our once-daily formulation of bromfenac sodium ophthalmic solution for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract extraction.  We believe the introduction of the first and only once-daily non-steroidal anti-inflammatory (NSAID) prescription eye drop will help with treatment compliance and benefit patients recovering from cataract surgery.  Our sales forc
'/>"/>

SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. DUSA Pharmaceuticals, Inc.® to Host Third Quarter 2010 Corporate Highlights and Financial Results Conference Call
2. Access Pharmaceuticals Awarded $1.5 Million in Section 48D Grants
3. Anadys Pharmaceuticals to Report Third Quarter 2010 Financial Results
4. Alder Biopharmaceuticals Appoints Bruce Montgomery to Board of Directors
5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
6. AVANIR Pharmaceuticals Invites Investors to Conference Call Regarding FDA Approval of NUEDEXTA™ on Monday November 1, 2010
7. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
8. Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2010 Financial Results on November 5, 2010
9. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2010 Financial Results
10. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
11. MAP Pharmaceuticals to Present Data Showing Low Migraine Recurrence Rates With LEVADEX™ in FREEDOM-301 Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... 2014 According to ... by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), Instruments ... Application (Immunology, Oncology) & by End User ... MarketsandMarkets, provides a detailed overview of the ... trends, and strategies impacting the global glycomics ...
(Date:9/30/2014)... LOS ANGELES , Sept. 30, 2014   ... apnea shopping destination , today announced that it now ... ResMed . AirSense CPAPs are the first sleep apnea ... makes it simple and easy to track and share ... the overall effectiveness of their CPAP therapy.  In addition, ...
(Date:9/30/2014)... , Sept. 30, 2014 The Chinese ... ageing population and rise in the incidence of lifestyle ... wounds and in affordability of better quality of wound ... care market. Universal coverage of public health insurance schemes ... further stimulate demand. Based on the findings of primary ...
Breaking Medicine Technology:Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4China Wound Care Market 2China Wound Care Market 3
... SAN) and (NYSE: SNY)] announced today it has commenced a ... Genzyme Corporation (Nasdaq: GENZ ) for $69 per ... less any required withholding taxes.  The transaction is valued at ... sanofi-aventis, Board of Directors, is scheduled to expire at 11:59 ...
... Nephros, Inc. (OTC Bulletin Board: NEPH ... products for therapeutic applications, infection control, and water purification, ... bridge financing agreement with Lambda Investors LLC and has ... its stockholders.  Wexford Capital LP is the managing member ...
Cached Medicine Technology:Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 2Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 3Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 4Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 5Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 6Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash 7Nephros Completes Bridge Financing and Announces Stockholder Rights Offering 2Nephros Completes Bridge Financing and Announces Stockholder Rights Offering 3Nephros Completes Bridge Financing and Announces Stockholder Rights Offering 4
(Date:9/30/2014)... EverStryke , the permanent match currently offered by ... a free book and class all about survival education and ... investigative review. , “Joe Marshall of SurvivalLife.com is one ... niche, and this product is an excellent way to get ... that Joe offers on his website to help people be ...
(Date:9/30/2014)... 30, 2014 Elevate , the latest ... better in and out of the gym by providing natural ... the attention of Shane Michaels, prompting an investigative review. ... the reason most people simply just don’t have the ability ... focused at work, getting the motivation to finish a project, ...
(Date:9/30/2014)... CA (PRWEB) September 30, 2014 ... providers in Turkey has gone up more than 79 ... The medical tourism company also reported total revenue tripled ... 2012. , The company’s professional strategy has allowed them ... — ultimately designed for patient comfort and privacy — ...
(Date:9/30/2014)... Plains, NY (PRWEB) September 30, 2014 ... recently hosted its annual “In Celebration” gala, honoring ... the nonprofit’s mission of striving to provide extraordinary ... and families facing a serious or life-limiting illness. ... Country Club in Rye, NY and recognized William ...
(Date:9/30/2014)... September 30, 2014 Regenerative Medicine Solutions ... new clinics in Nashville, Tennessee. RMS welcomes the launch ... and the expansion of a new treatment center for ... the Sleep Apnea Institute to Nashville, the hope is ... sleep apnea: both diagnosed and undiagnosed. With Nashville being ...
Breaking Medicine News(10 mins):Health News:EverStryke: Review Exposes Joe Marshall’s Permanent Match Survival Product 2Health News:Elevate: Review Exposes Blue Star Nutraceutical’s Latest Supplement for Ultimate Brain Function, Focus, and Energy 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 2Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 3Health News:VisitandCare.com Announces Record Demand for Plastic Surgery in Turkey 4Health News:Hospice & Palliative Care of Westchester Honors Outstanding Individuals at Annual ‘In Celebration’ Gala 2Health News:Regenerative Medicine Solutions Expanding 2
... Oct. 2 APWU Health Plan is proud to announce ... High Option sees a four percent increase in it,s rate, ... increase. APWU Health Plan is offering the same comprehensive ... adding new benefits and enhancing old ones. We will ...
... in study , FRIDAY, Oct. 2 (HealthDay News) -- Children ... likely to be convicted of violent crimes as adults, a ... looked at data on 17,415 children born in a single ... from the British Cohort Study, included detailed health and lifestyle ...
... of dentists and reaffirms patient advocacy , HONOLULU, ... of its 150th birthday will culminate with tonight,s spectacular program, ... "The ADA,s 150th anniversary is a very significant achievement in ... President John S. Findley, D.D.S. "It also is a ...
... Oct. 2 Beginning October 1st, The Peninsula Chicago will ... Awareness Month and several cancer research and education organizations. , ... breast cancer in some way and this is why we ... Maria Zec, general manager of The Peninsula Chicago. "In addition ...
... study patients , FRIDAY, Oct. 2 (HealthDay News) -- ... for surgery in ulcerative colitis patients by almost half, ... inflammation of the colon and often leads to surgical ... 728 patients who received either an inactive placebo or ...
... linked to reduced risk, study finds , FRIDAY, Oct. ... can reduce the risk of falls in seniors, say researchers ... participants aged 65 and older. , The analysis revealed that ... vitamin D per day (vitamin D2 or D3) reduces falls ...
Cached Medicine News:Health News:Daily Candy in Childhood Linked to Violence in Adulthood 2Health News:Daily Candy in Childhood Linked to Violence in Adulthood 3Health News:ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 2Health News:ADA Culminates Yearlong 150th Anniversary Observance at Its 150th Annual Session 3Health News:The Peninsula Chicago Gives Back During Breast Cancer Awareness Month 2Health News:Daily Dose of Vitamin D Helps Prevent Falls in Seniors 2
Stryker autoclavable pediatric laparoscopes provide equivalent brightness and resolution along with the unparalleled durability found in larger laparoscopes....
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
Bactron IV is designed for high volume, yet requires far less bench space than expected for its capacity and performance features....
Designed for larger laboratories or research applications, the Concept 1000 boasts some very unique features....
Medicine Products: